4.7 Article

Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method

Related references

Note: Only part of the references are listed.
Review Radiology, Nuclear Medicine & Medical Imaging

Rectal MRI Interpretation After Neoadjuvant Therapy

Natally Horvat et al.

Summary: In recent years, there have been significant advancements in the management of locally advanced rectal cancer, including surgical approaches, neoadjuvant chemoradiotherapy, and organ preservation strategies. This review focuses on the role of rectal MRI in assessing treatment response after neoadjuvant therapy and discusses the challenges and methods in evaluating treatment response.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Oncology

Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial

Francesco Marchegiani et al.

Summary: The short-term outcomes of rectum-preservation for locally advanced rectal cancer patients achieving major clinical response or complete clinical response after neoadjuvant therapy were reported in the study. Transanal local excision for patients achieving cCR or mCR is safe, with an increased cCR rate seen when there is a 12-week interval from chemoradiotherapy completion to LE. Performing LE after achieving cCR reduces the risk of ypT >.

ANNALS OF SURGICAL ONCOLOGY (2022)

Review Oncology

Lateral Lymph Nodes in Rectal Cancer: Do we all Think the Same? A Review of Multidisciplinary Obstacles and Treatment Recommendations

Tania C. Sluckin et al.

Summary: Lateral lymph nodes in low, locally advanced, rectal cancer have significant implications for local recurrence rates. However, there is currently no consensus on the treatment of lateral nodal disease, leading to challenges in multidisciplinary collaboration.

CLINICAL COLORECTAL CANCER (2022)

Review Oncology

Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer

Hidde M. Kroon et al.

Summary: This systematic review and meta-analysis investigated the long-term oncological outcomes of neoadjuvant (chemo)radiotherapy followed by total mesorectal excision (TME) with or without lateral lymph node dissection (LLND) in patients with pre-treatment metastatic lateral lymph nodes (LLNs). It was found that LLND reduced the risk of local recurrence, but did not significantly affect disease-free or overall survival.
Article Radiology, Nuclear Medicine & Medical Imaging

Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus

Doenja M. J. Lambregts et al.

Summary: This study aims to identify the main problem areas in the applicability of the current TNM staging system for rectal cancer, and provide recommendations on how to handle them. A global case-based online survey was conducted, and 16 problem areas were identified, including issues with cT staging, disease definitions, mesorectal fascia involvement, evaluation of lymph nodes and tumor deposits, and staging of lateral lymph nodes. The recommendations derived from this study may serve as a practice guide and support tool for radiologists involved in the staging of rectal cancer.

EUROPEAN RADIOLOGY (2022)

Review Oncology

Watch and wait: Why, to whom and how

Carlos Cerdan-Santacruz et al.

Summary: The current standard of care for locally advanced rectal cancer includes neoadjuvant chemo-radiation followed by total mesorectal excision. However, the watch and wait strategy (W&W), which involves close surveillance without immediate surgery, has become an attractive alternative in selected patients who achieve complete tumor regression. This approach offers the potential benefits of avoiding radical surgery, but the risk of local tumor regrowth must be carefully considered. This article explores the advantages and disadvantages of W&W and highlights the key issues related to staging, treatment regimens, and tumor response assessment that need to be addressed for successful implementation of this strategy. In the context of contemporary neoadjuvant treatment regimens, achieving a clinical complete response is likely to impact a significant proportion of patients, and with evolving imaging technologies, W&W is expected to become an integral part of multidisciplinary management decisions.

SURGICAL ONCOLOGY-OXFORD (2022)

Review Medicine, General & Internal

Lymph Nodes Evaluation in Rectal Cancer: Where Do We Stand and Future Perspective

Alessandra Borgheresi et al.

Summary: The assessment of nodal involvement in rectal cancer patients is crucial for disease management, but the traditional dimensional and morphological criteria have limitations. Various imaging techniques have been introduced to improve the accuracy of nodal staging, and radiomics analysis has provided valuable evidence. Additionally, there are differences in recommendations for nodal evaluation in rectal cancer between European and North American guidelines.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Oncology

Magnetic Resonance Imaging Evaluation of the Accuracy of Various Lymph Node Staging Criteria in Rectal Cancer: A Systematic Review and Meta-Analysis

Zixuan Zhuang et al.

Summary: This systematic review evaluated the diagnostic performance of MRI in lymph node staging for rectal cancer. The results showed that MRI scans have minimal accuracy as a reference index for pretreatment staging of various lymph node staging criteria in rectal cancer. It is recommended to use multiple types of evidence in clinical decision-making.

FRONTIERS IN ONCOLOGY (2021)

Article Surgery

Prevalence of nodal involvement in rectal cancer after chemoradiotherapy

H. E. Haak et al.

Summary: This study found that the risk of nodal metastases (ypN+) after chemoradiotherapy increases with advancing ypT category in locally advanced rectal cancer patients. Patients with ypN+ disease had lower 5-year disease-free survival and overall survival rates than patients with ypN0 tumors, with ypN+ status being an independent predictor of recurrence and death. Therefore, the presence of residual cancer cells in lymph nodes following (chemo)radiotherapy should be considered in treatment decision-making, especially when contemplating organ-preserving strategies.

BRITISH JOURNAL OF SURGERY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

The Diagnostic Accuracy of Magnetic Resonance Imaging in Restaging of Rectal Cancer After Preoperative Chemoradiotherapy: A Meta-Analysis and Systematic Review

Ming-Zhu Wei et al.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management

Natally Horvat et al.

RADIOGRAPHICS (2019)

Review Oncology

Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology

Al B. Benson et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)

Article Gastroenterology & Hepatology

Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy

Fabio Pomerri et al.

DISEASES OF THE COLON & RECTUM (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

DWI for Assessment of Rectal Cancer Nodes After Chemoradiotherapy: Is the Absence of Nodes at DWI Proof of a Negative Nodal Status?

Miriam M. van Heeswijk et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2017)

Article Gastroenterology & Hepatology

Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging?

Luc A. Heijnen et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

Patrick M. Bossuyt et al.

RADIOLOGY (2015)